LinkedIn Profile

Access Coherus BioSciences historical Linkedin company profile data on number of followers, employee headcount and more

Rows

Open dataset
Ticker Symbol Entity Name As Of Date Company Name Followers Employees on Linkedin Link Industry Date Added Date Updated Description Website Specialities Logo HQ.Street HQ.City HQ.State HQ.Country HQ.Postal Headcount change in past 24 months Company Name Sector Industry
nasdaq:chrs 2583026 Apr 14th, 2024 12:00AM Coherus BioSciences 33K 326.00 Open Apr 13th, 2024 10:47PM Apr 14th, 2024 10:46AM Coherus is a commercial-stage biopharmaceutical company focused on the research, development, and commercialization of innovative immunotherapies to treat cancer and the commercialization of our portfolio of FDA-approved therapeutics. We are building a leading oncology company backed by in-house expertise and an established infrastructure from our diversified portfolio of FDA-approved biosimilar products. If you are interested in joining a highly innovative and exciting company, please visit our careers webpage at http://www.coherus.com/careers/ for a list of career opportunities. Open biotechnology, biosimilars, and Immuno-oncology Open 333 Twin Dolphin Drive, Suite 600 Redwood City CA US 94065 Coherus BioSciences Health Care Pharmaceuticals & Biotechnology
nasdaq:chrs 2583026 Apr 13th, 2024 12:00AM Coherus BioSciences 33K 326.00 Open Apr 12th, 2024 10:38PM Apr 13th, 2024 11:13AM Coherus is a commercial-stage biopharmaceutical company focused on the research, development, and commercialization of innovative immunotherapies to treat cancer and the commercialization of our portfolio of FDA-approved therapeutics. We are building a leading oncology company backed by in-house expertise and an established infrastructure from our diversified portfolio of FDA-approved biosimilar products. If you are interested in joining a highly innovative and exciting company, please visit our careers webpage at http://www.coherus.com/careers/ for a list of career opportunities. Open biotechnology, biosimilars, and Immuno-oncology Open 333 Twin Dolphin Drive, Suite 600 Redwood City CA US 94065 Coherus BioSciences Health Care Pharmaceuticals & Biotechnology
nasdaq:chrs 2583026 Apr 12th, 2024 12:00AM Coherus BioSciences 33K 326.00 Open Apr 11th, 2024 10:42PM Apr 12th, 2024 08:08AM Coherus is a commercial-stage biopharmaceutical company focused on the research, development, and commercialization of innovative immunotherapies to treat cancer and the commercialization of our portfolio of FDA-approved therapeutics. We are building a leading oncology company backed by in-house expertise and an established infrastructure from our diversified portfolio of FDA-approved biosimilar products. If you are interested in joining a highly innovative and exciting company, please visit our careers webpage at http://www.coherus.com/careers/ for a list of career opportunities. Open biotechnology, biosimilars, and Immuno-oncology Open 333 Twin Dolphin Drive, Suite 600 Redwood City CA US 94065 Coherus BioSciences Health Care Pharmaceuticals & Biotechnology
nasdaq:chrs 2583026 Apr 11th, 2024 12:00AM Coherus BioSciences 33K 328.00 Open Apr 10th, 2024 11:15PM Apr 11th, 2024 10:53AM Coherus is a commercial-stage biopharmaceutical company focused on the research, development, and commercialization of innovative immunotherapies to treat cancer and the commercialization of our portfolio of FDA-approved therapeutics. We are building a leading oncology company backed by in-house expertise and an established infrastructure from our diversified portfolio of FDA-approved biosimilar products. If you are interested in joining a highly innovative and exciting company, please visit our careers webpage at http://www.coherus.com/careers/ for a list of career opportunities. Open biotechnology, biosimilars, and Immuno-oncology Open 333 Twin Dolphin Drive, Suite 600 Redwood City CA US 94065 Coherus BioSciences Health Care Pharmaceuticals & Biotechnology
nasdaq:chrs 2583026 Apr 10th, 2024 12:00AM Coherus BioSciences 33K 328.00 Open Apr 9th, 2024 10:46PM Apr 10th, 2024 05:01PM Coherus is a commercial-stage biopharmaceutical company focused on the research, development, and commercialization of innovative immunotherapies to treat cancer and the commercialization of our portfolio of FDA-approved therapeutics. We are building a leading oncology company backed by in-house expertise and an established infrastructure from our diversified portfolio of FDA-approved biosimilar products. If you are interested in joining a highly innovative and exciting company, please visit our careers webpage at http://www.coherus.com/careers/ for a list of career opportunities. Open biotechnology, biosimilars, and Immuno-oncology Open 333 Twin Dolphin Drive, Suite 600 Redwood City CA US 94065 Coherus BioSciences Health Care Pharmaceuticals & Biotechnology
nasdaq:chrs 2583026 Apr 9th, 2024 12:00AM Coherus BioSciences 33K 329.00 Open Apr 8th, 2024 10:57PM Apr 9th, 2024 09:43AM Coherus is a commercial-stage biopharmaceutical company focused on the research, development, and commercialization of innovative immunotherapies to treat cancer and the commercialization of our portfolio of FDA-approved therapeutics. We are building a leading oncology company backed by in-house expertise and an established infrastructure from our diversified portfolio of FDA-approved biosimilar products. If you are interested in joining a highly innovative and exciting company, please visit our careers webpage at http://www.coherus.com/careers/ for a list of career opportunities. Open biotechnology, biosimilars, and Immuno-oncology Open 333 Twin Dolphin Drive, Suite 600 Redwood City CA US 94065 Coherus BioSciences Health Care Pharmaceuticals & Biotechnology
nasdaq:chrs 2583026 Apr 8th, 2024 12:00AM Coherus BioSciences 33K 329.00 Open Apr 7th, 2024 11:22PM Apr 8th, 2024 06:41PM Coherus is a commercial-stage biopharmaceutical company focused on the research, development, and commercialization of innovative immunotherapies to treat cancer and the commercialization of our portfolio of FDA-approved therapeutics. We are building a leading oncology company backed by in-house expertise and an established infrastructure from our diversified portfolio of FDA-approved biosimilar products. If you are interested in joining a highly innovative and exciting company, please visit our careers webpage at http://www.coherus.com/careers/ for a list of career opportunities. Open biotechnology, biosimilars, and Immuno-oncology Open 333 Twin Dolphin Drive, Suite 600 Redwood City CA US 94065 Coherus BioSciences Health Care Pharmaceuticals & Biotechnology
nasdaq:chrs 2583026 Apr 7th, 2024 12:00AM Coherus BioSciences 33K 329.00 Open Apr 6th, 2024 10:53PM Apr 6th, 2024 10:53PM Coherus is a commercial-stage biopharmaceutical company focused on the research, development, and commercialization of innovative immunotherapies to treat cancer and the commercialization of our portfolio of FDA-approved therapeutics. We are building a leading oncology company backed by in-house expertise and an established infrastructure from our diversified portfolio of FDA-approved biosimilar products. If you are interested in joining a highly innovative and exciting company, please visit our careers webpage at http://www.coherus.com/careers/ for a list of career opportunities. Open biotechnology, biosimilars, and Immuno-oncology Open 333 Twin Dolphin Drive, Suite 600 Redwood City CA US 94065 Coherus BioSciences Health Care Pharmaceuticals & Biotechnology
nasdaq:chrs 2583026 Apr 6th, 2024 12:00AM Coherus BioSciences 33K 330.00 Open Apr 5th, 2024 10:53PM Apr 5th, 2024 10:53PM Coherus is a commercial-stage biopharmaceutical company focused on the research, development, and commercialization of innovative immunotherapies to treat cancer and the commercialization of our portfolio of FDA-approved therapeutics. We are building a leading oncology company backed by in-house expertise and an established infrastructure from our diversified portfolio of FDA-approved biosimilar products. If you are interested in joining a highly innovative and exciting company, please visit our careers webpage at http://www.coherus.com/careers/ for a list of career opportunities. Open biotechnology, biosimilars, and Immuno-oncology Open 333 Twin Dolphin Drive, Suite 600 Redwood City CA US 94065 Coherus BioSciences Health Care Pharmaceuticals & Biotechnology
nasdaq:chrs 2583026 Apr 5th, 2024 12:00AM Coherus BioSciences 33K 329.00 Open Apr 4th, 2024 11:20PM Apr 4th, 2024 11:20PM Coherus is a commercial-stage biopharmaceutical company focused on the research, development, and commercialization of innovative immunotherapies to treat cancer and the commercialization of our portfolio of FDA-approved therapeutics. We are building a leading oncology company backed by in-house expertise and an established infrastructure from our diversified portfolio of FDA-approved biosimilar products. If you are interested in joining a highly innovative and exciting company, please visit our careers webpage at http://www.coherus.com/careers/ for a list of career opportunities. Open biotechnology, biosimilars, and Immuno-oncology Open 333 Twin Dolphin Drive, Suite 600 Redwood City CA US 94065 Coherus BioSciences Health Care Pharmaceuticals & Biotechnology

Request a demo to view additional historical data, and much more.

Request Demo

Make fast
queries

No longer rely on engineers to access data; build and share queries with intuitive tools, and derive insights in real time.

Bookmark queries with your team

Save and share custom queries using a private bookmarking feature, accessible to your whole team.

Be first to know with alerts

Scan data points across millions of companies and receive emails when relevant metrics cross critical thresholds.

Visualize data for quick insights

Create custom keyword-based word clouds, charts, and advanced visualizations to quickly analyze the data.

Map competitor locations

Analyze competitor presence and growth over time by overlaying store locations with the Nearby Competitor feature.

Add widgets to your dashboards

Access existing maps, charts, word clouds, and other visualizations to understand your data quickly. Or build custom widgets to view data just the way you want it.